Cargando…

A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma

BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: Thi...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Wenle, Wang, Bing, Dong, Shengtao, Xu, Chan, Song, Yang, Qiao, Ximin, Xu, Xiaofeng, Huang, Meijin, Yin, Chengliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035798/
https://www.ncbi.nlm.nih.gov/pubmed/35480102
http://dx.doi.org/10.3389/fonc.2022.851552
_version_ 1784693377659305984
author Li, Wenle
Wang, Bing
Dong, Shengtao
Xu, Chan
Song, Yang
Qiao, Ximin
Xu, Xiaofeng
Huang, Meijin
Yin, Chengliang
author_facet Li, Wenle
Wang, Bing
Dong, Shengtao
Xu, Chan
Song, Yang
Qiao, Ximin
Xu, Xiaofeng
Huang, Meijin
Yin, Chengliang
author_sort Li, Wenle
collection PubMed
description BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: This study included patients with RCC from 2010 to 2018 in the Surveillance, Epidemiology, and Final Results (SEER) database into the training cohort and included the RCC patients diagnosed during the same period in the Second Affiliated Hospital of Dalian Medical University into the validation cohort. Univariate and multivariate logistic regression analysis were performed to identify risk factors for LM, constructing a nomogram. The receiver operating characteristic (ROC) curves were generated to assess the nomogram’s performance, and the concordance index (C-index), area under curve value (AUC), and calibration plots were used to evaluate the discrimination and calibration of the nomogram. The nomogram’s clinical performance was evaluated by decision curve analysis (DCA), probability density function (PDF) and clinical utility curve (CUC). Furthermore, Kaplan-Meier curves were performed in the training and the validation cohort to evaluate the survival risk of the patients with lymphatic metastasis or not. Additionally, on the basis of the constructed nomogram, we obtained a convenient and intuitive network calculator. RESULTS: A total of 41837 patients were included for analysis, including 41,018 in the training group and 819 in the validation group. Eleven risk factors were considered as predictor variables in the nomogram. The nomogram displayed excellent discrimination power, with AUC both reached 0.916 in the training group (95% confidence interval (CI) 0.913 to 0.918) and the validation group (95% CI 0.895 to 0.934). The calibration curves presented that the nomogram-based prediction had good consistency with practical application. Moreover, Kaplan-Meier curves analysis showed that RCC patients with LMs had worse survival outcomes compared with patients without LMs. CONCLUSIONS: The nomogram and web calculator (https://liwenle0910.shinyapps.io/DynNomapp/) may be a useful tool to quantify the risk of LMs in patients with RCC, which may provide guidance for clinicians, such as identifying high-risk patients, performing surgery, and establishing personalized treatment as soon as possible.
format Online
Article
Text
id pubmed-9035798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-90357982022-04-26 A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma Li, Wenle Wang, Bing Dong, Shengtao Xu, Chan Song, Yang Qiao, Ximin Xu, Xiaofeng Huang, Meijin Yin, Chengliang Front Oncol Oncology BACKGROUND: Lymphatic metastasis is an important mechanism of renal cell carcinoma (RCC) dissemination and is an indicator of poor prognosis. Therefore, we aimed to identify predictors of lymphatic metastases (LMs) in RCC patients and to develop a new nomogram to assess the risk of LMs. METHODS: This study included patients with RCC from 2010 to 2018 in the Surveillance, Epidemiology, and Final Results (SEER) database into the training cohort and included the RCC patients diagnosed during the same period in the Second Affiliated Hospital of Dalian Medical University into the validation cohort. Univariate and multivariate logistic regression analysis were performed to identify risk factors for LM, constructing a nomogram. The receiver operating characteristic (ROC) curves were generated to assess the nomogram’s performance, and the concordance index (C-index), area under curve value (AUC), and calibration plots were used to evaluate the discrimination and calibration of the nomogram. The nomogram’s clinical performance was evaluated by decision curve analysis (DCA), probability density function (PDF) and clinical utility curve (CUC). Furthermore, Kaplan-Meier curves were performed in the training and the validation cohort to evaluate the survival risk of the patients with lymphatic metastasis or not. Additionally, on the basis of the constructed nomogram, we obtained a convenient and intuitive network calculator. RESULTS: A total of 41837 patients were included for analysis, including 41,018 in the training group and 819 in the validation group. Eleven risk factors were considered as predictor variables in the nomogram. The nomogram displayed excellent discrimination power, with AUC both reached 0.916 in the training group (95% confidence interval (CI) 0.913 to 0.918) and the validation group (95% CI 0.895 to 0.934). The calibration curves presented that the nomogram-based prediction had good consistency with practical application. Moreover, Kaplan-Meier curves analysis showed that RCC patients with LMs had worse survival outcomes compared with patients without LMs. CONCLUSIONS: The nomogram and web calculator (https://liwenle0910.shinyapps.io/DynNomapp/) may be a useful tool to quantify the risk of LMs in patients with RCC, which may provide guidance for clinicians, such as identifying high-risk patients, performing surgery, and establishing personalized treatment as soon as possible. Frontiers Media S.A. 2022-04-11 /pmc/articles/PMC9035798/ /pubmed/35480102 http://dx.doi.org/10.3389/fonc.2022.851552 Text en Copyright © 2022 Li, Wang, Dong, Xu, Song, Qiao, Xu, Huang and Yin https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Li, Wenle
Wang, Bing
Dong, Shengtao
Xu, Chan
Song, Yang
Qiao, Ximin
Xu, Xiaofeng
Huang, Meijin
Yin, Chengliang
A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title_full A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title_fullStr A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title_full_unstemmed A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title_short A Novel Nomogram for Prediction and Evaluation of Lymphatic Metastasis in Patients With Renal Cell Carcinoma
title_sort novel nomogram for prediction and evaluation of lymphatic metastasis in patients with renal cell carcinoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9035798/
https://www.ncbi.nlm.nih.gov/pubmed/35480102
http://dx.doi.org/10.3389/fonc.2022.851552
work_keys_str_mv AT liwenle anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT wangbing anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT dongshengtao anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT xuchan anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT songyang anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT qiaoximin anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT xuxiaofeng anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT huangmeijin anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT yinchengliang anovelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT liwenle novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT wangbing novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT dongshengtao novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT xuchan novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT songyang novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT qiaoximin novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT xuxiaofeng novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT huangmeijin novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma
AT yinchengliang novelnomogramforpredictionandevaluationoflymphaticmetastasisinpatientswithrenalcellcarcinoma